Insider acquisitions
Explore purchases, stock awards, gifts, exercises, and conversions. These records cover acquisitions only; sales are not included.
Transaction timeline & trade size
Choose a reporting owner, transaction period, and security. Open any point for the filing.
Purchases in this page50
Other acquisitions0
Reporting owners19
SalesNot providedCheck original SEC filings
Dec 16, 2025 – Dec 18, 2025 · Transaction dates · Current page sample
Reported quantity · security units
NEW GERMANY FUND INC · Common Stock · Purchase (code P) · Non-derivative · Currency not specified
Swipe the chart to see the full date range. Exact records are available in the table below.
2 transactions plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition
50 dated transactions in this page sample · 19 reporting owners.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type | Quantity | Price | Reference value | Currency |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | NEW GERMANY FUND INCCommon Stock | Saba Capital Management, L.P. (10% owner) | Purchase | 4,399 | 11.25 | 49,488.75 | Currency not specified |
| Dec 16, 2025 | NEW GERMANY FUND INCCommon Stock | Saba Capital Management, L.P. (10% owner) | Purchase | 9,643 | 11.35 | 109,448.05 | Currency not specified |
| Dec 16, 2025 | MEXICO FUND INCCommon Stock | Saba Capital Management, L.P. (10% owner) | Purchase | 16,228 | 19.95 | 323,748.6 | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Prudo-Chlebosz Raymond (Director) | Purchase | 386,661 | 0.4041 | 156,249.7101 | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase ADRs | Prudo-Chlebosz Raymond (Director) | Purchase | 386,661 | Not reported | Not reported | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Prudo-Chlebosz Raymond (Director) | Purchase | 618,658 | 0.4041 | 249,999.6978 | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs") | Prudo-Chlebosz Raymond (Director) | Purchase | 618,658 | Not reported | Not reported | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Patel Sandip I (Director) | Purchase | 154,664 | 0.4041 | 62,499.7224 | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase ADRs | Patel Sandip I (Director) | Purchase | 154,664 | Not reported | Not reported | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Patel Sandip I (Director) | Purchase | 247,462 | 0.4041 | 99,999.3942 | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs") | Patel Sandip I (Director) | Purchase | 247,462 | Not reported | Not reported | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Huh Hoyoung (Director · 10% owner) | Purchase | 3,093,293 | 0.4041 | 1,249,999.7013 | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase ADRs | Huh Hoyoung (Director · 10% owner) | Purchase | 3,093,293 | Not reported | Not reported | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Huh Hoyoung (Director · 10% owner) | Purchase | 618,658 | 0.4041 | 249,999.6978 | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs") | Huh Hoyoung (Director · 10% owner) | Purchase | 618,658 | Not reported | Not reported | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Farag Kameel D. (Interim CFO) | Purchase | 24,745 | 0.4041 | 9,999.4545 | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs") | Farag Kameel D. (Interim CFO) | Purchase | 24,745 | Not reported | Not reported | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Patel Samir Rashmikant (Director · 10% owner) | Purchase | 231,997 | 0.4041 | 93,749.9877 | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase ADRs | Patel Samir Rashmikant (Director · 10% owner) | Purchase | 231,997 | Not reported | Not reported | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Patel Samir Rashmikant (Director · 10% owner) | Purchase | 618,658 | 0.4041 | 249,999.6978 | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs") | Patel Samir Rashmikant (Director · 10% owner) | Purchase | 618,658 | Not reported | Not reported | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Gaslightwala Abizer (CEO · Director) | Purchase | 773,323 | 0.4041 | 312,499.8243 | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase ADRs | Gaslightwala Abizer (CEO · Director) | Purchase | 773,323 | Not reported | Not reported | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Gaslightwala Abizer (CEO · Director) | Purchase | 309,328 | 0.4041 | 124,999.4448 | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs") | Gaslightwala Abizer (CEO · Director) | Purchase | 309,328 | Not reported | Not reported | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Bazemore Robert B (Director) | Purchase | 30,932 | 0.4041 | 12,499.6212 | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase ADRs | Bazemore Robert B (Director) | Purchase | 30,932 | Not reported | Not reported | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Bazemore Robert B (Director) | Purchase | 123,731 | 0.4041 | 49,999.6971 | Currency not specified |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs") | Bazemore Robert B (Director) | Purchase | 123,731 | Not reported | Not reported | Currency not specified |
| Dec 16, 2025 | CALLAN JMB INC.Common Stock | Williams Wayne D (CEO, Chairman and President · Director · 10% owner) | Purchase | 5,000 | 1.73 | 8,650 | Currency not specified |
| Dec 18, 2025 | Prairie Operating Co.Common Stock | Narrogal Nominees Pty Ltd (10% owner) · Narrogal Nominees Pty Ltd ATF Gregory K O'Neill Family Trust (10% owner) · O'Neill Gregory K (10% owner) | Purchase | 36,701 | 1.68 | 61,657.68 | Currency not specified |
| Dec 17, 2025 | Prairie Operating Co.Common Stock | Narrogal Nominees Pty Ltd (10% owner) · Narrogal Nominees Pty Ltd ATF Gregory K O'Neill Family Trust (10% owner) · O'Neill Gregory K (10% owner) | Purchase | 20,795 | 1.6787 | 34,908.5665 | Currency not specified |
| Dec 17, 2025 | Prairie Operating Co.Common Stock | Narrogal Nominees Pty Ltd (10% owner) · Narrogal Nominees Pty Ltd ATF Gregory K O'Neill Family Trust (10% owner) · O'Neill Gregory K (10% owner) | Purchase | 50,000 | 1.68 | 84,000 | Currency not specified |
| Dec 16, 2025 | Prairie Operating Co.Common Stock | Narrogal Nominees Pty Ltd (10% owner) · Narrogal Nominees Pty Ltd ATF Gregory K O'Neill Family Trust (10% owner) · O'Neill Gregory K (10% owner) | Purchase | 36,022 | 1.679 | 60,480.938 | Currency not specified |
| Dec 16, 2025 | Prairie Operating Co.Common Stock | Narrogal Nominees Pty Ltd (10% owner) · Narrogal Nominees Pty Ltd ATF Gregory K O'Neill Family Trust (10% owner) · O'Neill Gregory K (10% owner) | Purchase | 50,000 | 1.68 | 84,000 | Currency not specified |
| Dec 17, 2025 | Silvia, Inc.Common Stock, par value $0.001 | Pompliano Anthony John III (Chief Executive Officer · Director · 10% owner) | Purchase | 298,000 | 3.37 | 1,004,260 | Currency not specified |
| Dec 17, 2025 | RENN Fund, Inc.Common Stock | STAHL MURRAY (President/Co-Portfolio Manager · 10% owner) | Purchase | 82 | 2.65 | 217.3 | Currency not specified |
| Dec 17, 2025 | RENN Fund, Inc.Common Stock | STAHL MURRAY (President/Co-Portfolio Manager · 10% owner) | Purchase | 18 | 2.65 | 47.7 | Currency not specified |
| Dec 17, 2025 | RENN Fund, Inc.Common Stock | STAHL MURRAY (President/Co-Portfolio Manager · 10% owner) | Purchase | 296 | 2.65 | 784.4 | Currency not specified |
| Dec 17, 2025 | RENN Fund, Inc.Common Stock | STAHL MURRAY (President/Co-Portfolio Manager · 10% owner) | Purchase | 180 | 2.65 | 477 | Currency not specified |
| Dec 17, 2025 | RENN Fund, Inc.Common Stock | STAHL MURRAY (President/Co-Portfolio Manager · 10% owner) | Purchase | 180 | 2.65 | 477 | Currency not specified |
| Dec 17, 2025 | RENN Fund, Inc.Common Stock | STAHL MURRAY (President/Co-Portfolio Manager · 10% owner) | Purchase | 18 | 2.65 | 47.7 | Currency not specified |
| Dec 17, 2025 | RENN Fund, Inc.Common Stock | STAHL MURRAY (President/Co-Portfolio Manager · 10% owner) | Purchase | 360 | 2.65 | 954 | Currency not specified |
| Dec 17, 2025 | Texas Pacific Land CorpCommon Stock | HORIZON KINETICS ASSET MANAGEMENT LLC (10% owner) | Purchase | 1 | 879.93 | 879.93 | Currency not specified |
| Dec 17, 2025 | ELUTIA INC.Class A Common Stock | Makes Brigid (Director) | Purchase | 25,000 | 0.52 | 13,000 | Currency not specified |
| Dec 17, 2025 | ELUTIA INC.Class A Common Stock | Mills C Randal (PRESIDENT AND CEO · Director) | Purchase | 3,000 | 0.51 | 1,530 | Currency not specified |
| Dec 18, 2025 | GLOBAL PARTNERS LPCommon units representing limited partner interests | Global GP LLC (General Partner) | Purchase | 2,500 | 42.64 | 106,600 | Currency not specified |
| Dec 17, 2025 | GLOBAL PARTNERS LPCommon units representing limited partner interests | Global GP LLC (General Partner) | Purchase | 2,156 | 42.02 | 90,595.12 | Currency not specified |
| Dec 16, 2025 | GLOBAL PARTNERS LPCommon units representing limited partner interests | Global GP LLC (General Partner) | Purchase | 1,836 | 42.35 | 77,754.6 | Currency not specified |
| Dec 17, 2025 | ELUTIA INC.Class A Common Stock | Ferguson Matthew (CHIEF FINANCIAL OFFICER) | Purchase | 60,000 | 0.53 | 31,800 | Currency not specified |
Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transaction details
Reporting owners, quantities, prices, and source filings.
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Trade: | NEW GERMANY FUND INCGF · company listings | Saba Capital Management, L.P.10% owner | PurchaseCommon StockNon-derivative security · Code P | 4,399 | 11.25Value: 49,488.75Currency not specified | View ↗ |
| Trade: | NEW GERMANY FUND INCGF · company listings | Saba Capital Management, L.P.10% owner | PurchaseCommon StockNon-derivative security · Code P | 9,643 | 11.35Value: 109,448.05Currency not specified | View ↗ |
| Trade: | MEXICO FUND INCMXF · company listings | Saba Capital Management, L.P.10% owner | PurchaseCommon StockNon-derivative security · Code P | 16,228 | 19.95Value: 323,748.6Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Prudo-Chlebosz RaymondDirector | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 386,661 | 0.4041 *Value: 156,249.7101Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Prudo-Chlebosz RaymondDirector | PurchaseWarrants to purchase ADRsDerivative security · Code P | 386,661 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Prudo-Chlebosz RaymondDirector | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 618,658 | 0.4041 *Value: 249,999.6978Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Prudo-Chlebosz RaymondDirector | PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P | 618,658 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Patel Sandip IDirector | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 154,664 | 0.4041 *Value: 62,499.7224Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Patel Sandip IDirector | PurchaseWarrants to purchase ADRsDerivative security · Code P | 154,664 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Patel Sandip IDirector | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 247,462 | 0.4041 *Value: 99,999.3942Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Patel Sandip IDirector | PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P | 247,462 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Huh HoyoungDirector · 10% owner | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 3,093,293 | 0.4041 *Value: 1,249,999.7013Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Huh HoyoungDirector · 10% owner | PurchaseWarrants to purchase ADRsDerivative security · Code P | 3,093,293 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Huh HoyoungDirector · 10% owner | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 618,658 | 0.4041 *Value: 249,999.6978Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Huh HoyoungDirector · 10% owner | PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P | 618,658 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Farag Kameel D.Interim CFO | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 24,745 | 0.4041 *Value: 9,999.4545Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Farag Kameel D.Interim CFO | PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P | 24,745 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Patel Samir RashmikantDirector · 10% owner | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 231,997 | 0.4041 *Value: 93,749.9877Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Patel Samir RashmikantDirector · 10% owner | PurchaseWarrants to purchase ADRsDerivative security · Code P | 231,997 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Patel Samir RashmikantDirector · 10% owner | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 618,658 | 0.4041 *Value: 249,999.6978Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Patel Samir RashmikantDirector · 10% owner | PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P | 618,658 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Gaslightwala AbizerCEO · Director | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 773,323 | 0.4041 *Value: 312,499.8243Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Gaslightwala AbizerCEO · Director | PurchaseWarrants to purchase ADRsDerivative security · Code P | 773,323 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Gaslightwala AbizerCEO · Director | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 309,328 | 0.4041 *Value: 124,999.4448Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Gaslightwala AbizerCEO · Director | PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P | 309,328 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Bazemore Robert BDirector | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 30,932 | 0.4041 *Value: 12,499.6212Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Bazemore Robert BDirector | PurchaseWarrants to purchase ADRsDerivative security · Code P | 30,932 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Bazemore Robert BDirector | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 123,731 | 0.4041 *Value: 49,999.6971Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Bazemore Robert BDirector | PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P | 123,731 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | CALLAN JMB INC.CJMB · company listings | Williams Wayne DCEO, Chairman and President · Director · 10% owner | PurchaseCommon StockNon-derivative security · Code P | 5,000 | 1.73Value: 8,650Currency not specified | View ↗ |
| Trade: | Prairie Operating Co.PROP · company listings | Narrogal Nominees Pty Ltd10% owner O'Neill Gregory K10% owner Joint filing · amounts unallocated | PurchaseCommon StockNon-derivative security · Code P | 36,701 | 1.68Value: 61,657.68Currency not specified | View ↗ |
| Trade: | Prairie Operating Co.PROP · company listings | Narrogal Nominees Pty Ltd10% owner O'Neill Gregory K10% owner Joint filing · amounts unallocated | PurchaseCommon StockNon-derivative security · Code P | 20,795 | 1.6787Value: 34,908.5665Currency not specified | View ↗ |
| Trade: | Prairie Operating Co.PROP · company listings | Narrogal Nominees Pty Ltd10% owner O'Neill Gregory K10% owner Joint filing · amounts unallocated | PurchaseCommon StockNon-derivative security · Code P | 50,000 | 1.68Value: 84,000Currency not specified | View ↗ |
| Trade: | Prairie Operating Co.PROP · company listings | Narrogal Nominees Pty Ltd10% owner O'Neill Gregory K10% owner Joint filing · amounts unallocated | PurchaseCommon StockNon-derivative security · Code P | 36,022 | 1.679Value: 60,480.938Currency not specified | View ↗ |
| Trade: | Prairie Operating Co.PROP · company listings | Narrogal Nominees Pty Ltd10% owner O'Neill Gregory K10% owner Joint filing · amounts unallocated | PurchaseCommon StockNon-derivative security · Code P | 50,000 | 1.68Value: 84,000Currency not specified | View ↗ |
| Trade: | Silvia, Inc.SVIA · SVIAW · company listings | Pompliano Anthony John IIIChief Executive Officer · Director · 10% owner | PurchaseCommon Stock, par value $0.001Non-derivative security · Code P | 298,000 | 3.37Value: 1,004,260Currency not specified | View ↗ |
| Trade: | RENN Fund, Inc.RCG · company listings | STAHL MURRAYPresident/Co-Portfolio Manager · 10% owner | PurchaseCommon StockNon-derivative security · Code P | 82 | 2.65Value: 217.3Currency not specified | View ↗ |
| Trade: | RENN Fund, Inc.RCG · company listings | STAHL MURRAYPresident/Co-Portfolio Manager · 10% owner | PurchaseCommon StockNon-derivative security · Code P | 18 | 2.65Value: 47.7Currency not specified | View ↗ |
| Trade: | RENN Fund, Inc.RCG · company listings | STAHL MURRAYPresident/Co-Portfolio Manager · 10% owner | PurchaseCommon StockNon-derivative security · Code P | 296 | 2.65Value: 784.4Currency not specified | View ↗ |
| Trade: | RENN Fund, Inc.RCG · company listings | STAHL MURRAYPresident/Co-Portfolio Manager · 10% owner | PurchaseCommon StockNon-derivative security · Code P | 180 | 2.65Value: 477Currency not specified | View ↗ |
| Trade: | RENN Fund, Inc.RCG · company listings | STAHL MURRAYPresident/Co-Portfolio Manager · 10% owner | PurchaseCommon StockNon-derivative security · Code P | 180 | 2.65Value: 477Currency not specified | View ↗ |
| Trade: | RENN Fund, Inc.RCG · company listings | STAHL MURRAYPresident/Co-Portfolio Manager · 10% owner | PurchaseCommon StockNon-derivative security · Code P | 18 | 2.65Value: 47.7Currency not specified | View ↗ |
| Trade: | RENN Fund, Inc.RCG · company listings | STAHL MURRAYPresident/Co-Portfolio Manager · 10% owner | PurchaseCommon StockNon-derivative security · Code P | 360 | 2.65Value: 954Currency not specified | View ↗ |
| Trade: | Texas Pacific Land CorpTPL · company listings | PurchaseCommon StockNon-derivative security · Code P | 1 | 879.93Value: 879.93Currency not specified | View ↗ | |
| Trade: | ELUTIA INC.ELUT · company listings | Makes BrigidDirector | PurchaseClass A Common StockNon-derivative security · Code P | 25,000 | 0.52 *Value: 13,000Currency not specified | View ↗ |
| Trade: | ELUTIA INC.ELUT · company listings | Mills C RandalPRESIDENT AND CEO · Director | PurchaseClass A Common StockNon-derivative security · Code P | 3,000 | 0.51Value: 1,530Currency not specified | View ↗ |
| Trade: | GLOBAL PARTNERS LPGLP · company listings | Global GP LLCGeneral Partner | PurchaseCommon units representing limited partner interestsNon-derivative security · Code P | 2,500 | 42.64 *Value: 106,600Currency not specified | View ↗ |
| Trade: | GLOBAL PARTNERS LPGLP · company listings | Global GP LLCGeneral Partner | PurchaseCommon units representing limited partner interestsNon-derivative security · Code P | 2,156 | 42.02 *Value: 90,595.12Currency not specified | View ↗ |
| Trade: | GLOBAL PARTNERS LPGLP · company listings | Global GP LLCGeneral Partner | PurchaseCommon units representing limited partner interestsNon-derivative security · Code P | 1,836 | 42.35 *Value: 77,754.6Currency not specified | View ↗ |
| Trade: | ELUTIA INC.ELUT · company listings | Ferguson MatthewCHIEF FINANCIAL OFFICER | PurchaseClass A Common StockNon-derivative security · Code P | 60,000 | 0.53 *Value: 31,800Currency not specified | View ↗ |
50 transactions on this page. Filing date, newest first.
Filters use the date a filing was submitted, not the date of the transaction. Coverage is incomplete while historical records are being loaded. How we organize the data →